Proper diagnosis of OSD, dry eye hinges on right protocol in place

Article

Scott Schachter, OD, discusses dry eye disease, ocular surface disease, and developing protocols to diagnose both in his latest video blog.

The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.

Scott Schachter, OD, discusses dry eye disease, ocular surface disease, and developing protocols to diagnose both in his latest video blog.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
Related Content
Graphic of optometric office Image credit: ©mast3r - adobe.stock.com

What happened in optometry this week: December 2 - December 6

Jordana Joy, Associate Editor
December 7th 2024
Article
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO

Miriam Korik, OD;Tiffany Tsoi, OD;Emily Kaiser Maharjan, Assistant Managing Editor
December 4th 2024
Podcast
Doctor pointing to xray on computer Image credit: AdobeStock/xreflex

Study evaluates ocular tuberculosis and relapse rates for recurrence of uveitis

Lynda Charters
December 6th 2024
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
October 18th 2024
Podcast
Latinos en Optometry unveils Eying the Future program - Image credit: Adobe Stock / ©Gorodenkoff.jpeg

Eying the future: New school program seeks to fuel student interest in optometry

December 3rd 2024
Article
Man holding cigarette and whiskey glass at table Image credit: AdobeStock/Parkin

BMI, tobacco, and alcohol: Roles in glaucoma progression examined in study

Lynda Charters
December 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.